{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T02:33:27Z","timestamp":1795228407883,"version":"4.10.3"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Melatonin has wide-ranging effects on the body, including the regulation of circadian rhythm, and potentiation of cellular immune and antioxidant activities. In critically ill patients, endogenous melatonin has been shown to be markedly deranged and reduced. Therefore, the purpose of this systematic review and meta-analysis was to determine if exogenous supplementation of melatonin improves patient-centered outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>We searched five electronic databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection:<\/jats:title>\n                    <jats:p>Randomized clinical trials (RCTs) that compared melatonin to no melatonin in adults admitted to the ICU were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction:<\/jats:title>\n                    <jats:p>We aggregated data as relative risks, mean differences (MDs), and standard mean differences (SMDs) using a random-effects model. Supporting evidence for each effect was evaluated for certainty using the Grading Recommendations, Assessment, Development, and Evaluations approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>\n                      In total, 32 RCTs (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 3895 patients) were included. We found that melatonin may reduce delirium (relative risk [RR] 0.72; 95% CI, 0.58\u20130.89; low certainty), may slightly reduce ICU length of stay (MD \u20130.57 d; 95% CI, \u20130.95 to \u20130.18 d; low certainty), and may improve reported sleep quality (SMD 0.54; 95% CI, 0.01\u20131.07; low certainty). Melatonin may result in a slight reduction in the frequency of adverse events (low certainty). Evidence was uncertain with regards to the frequency of sleep awakenings, anxiety level, agitation, and post-traumatic stress disorder incidence (all very low certainty), as well as to ICU mortality and post-ICU functional status (both low certainty).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that melatonin administration in the critically ill may improve perceived sleep and reduce delirium, without increasing adverse effects. Certainty of evidence was negatively affected by the risk of bias and inconsistency. Future RCTs should focus on identifying optimal dosing, administration timing, improving measurements of sleep outcomes, and target populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006767","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:00:31Z","timestamp":1752588031000},"page":"e1714-e1724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Melatonin Use in the ICU: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"53","author":[{"given":"Brian Hao Yuan","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Manalo","sequence":"additional","affiliation":[{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifur R.","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Matthew","family":"Aldrich","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Perioperative Care, Critical Care Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald L.","family":"Weinhouse","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makayla","family":"Cordoza","sequence":"additional","affiliation":[{"name":"Critical Illness, Brain Dysfunction, and Survivorship Center, Nashville, TN."},{"name":"School of Nursing, Vanderbilt University, Nashville, TN."},{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R.","family":"Louzon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, AdventHealth Orlando, Orlando, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Balas","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, College of Nursing, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Stollings","sequence":"additional","affiliation":[{"name":"Critical Illness, Brain Dysfunction, and Survivorship Center, Nashville, TN."},{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"McNett","sequence":"additional","affiliation":[{"name":"College of Nursing, The Ohio State University, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dearness","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Estrada-Codecido","sequence":"additional","affiliation":[{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipayan","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada."},{"name":"Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kallirroi Laiya","family":"Carayannopoulos","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada."},{"name":"Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada."},{"name":"Department of Health Research, Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"R1-20250902","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00011.2014","article-title":"Melatonin: Exceeding expectations.","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology"},{"key":"R2-20250902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations.","volume":"52","author":"Venegas","year":"2012","journal-title":"J Pineal Res"},{"key":"R3-20250902","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/01.wnl.0000324283.57261.37","article-title":"Suprachiasmatic nucleus and melatonin: Reciprocal interactions and clinical correlations.","volume":"71","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"R4-20250902","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep.","volume":"15","author":"Cajochen","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"R5-20250902","doi-asserted-by":"crossref","first-page":"d1093","DOI":"10.2741\/1089","article-title":"Molecular pharmacology regulation and function of mammalian melatonin receptors.","volume":"8","author":"Dubocovich","year":"2003","journal-title":"Front Biosci"},{"key":"R6-20250902","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1152\/ajpregu.2000.278.3.R741","article-title":"Functional link between distal vasodilation and sleep-onset latency?","volume":"278","author":"Kr\u00e4uchi","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R7-20250902","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, functions and therapeutic benefits.","volume":"15","author":"Tordjman","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"R8-20250902","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3390\/ijms24054803","article-title":"Benefits of the neurogenic potential of melatonin for treating neurological and neuropsychiatric disorders.","volume":"24","author":"Potes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R9-20250902","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1749-6632.2000.tb05402.x","article-title":"Melatonin and its relation to the immune system and inflammation.","volume":"917","author":"Reiter","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 6","key":"R10-20250902","first-page":"115","article-title":"Melatonin and its influence on immune system.","volume":"58","author":"Szczepanik","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"R11-20250902","doi-asserted-by":"crossref","first-page":"P549","DOI":"10.1186\/cc14629","article-title":"Disturbed circadian rhythm in ICU patients as indicated by melatonin levels: A prospective pilot study.","volume":"19","author":"Kiss","year":"2015","journal-title":"Crit Care"},{"key":"R12-20250902","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/CCM.0000000000004333","article-title":"Factors disrupting melatonin secretion rhythms during critical illness.","volume":"48","author":"Maas","year":"2020","journal-title":"Crit Care Med"},{"key":"R13-20250902","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-079X.2009.00737.x","article-title":"Pharmacokinetics of orally administered melatonin in critically ill patients.","volume":"48","author":"Mistraletti","year":"2010","journal-title":"J Pineal Res"},{"key":"R14-20250902","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.0001-5172.2004.00401.x","article-title":"Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients.","volume":"48","author":"Olofsson","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"R15-20250902","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13613-021-00829-1","article-title":"Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation.","volume":"11","author":"Oxlund","year":"2021","journal-title":"Ann Intensive Care"},{"key":"R16-20250902","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1378\/chest.08-1546","article-title":"Sleep in the ICU: Potential mechanisms and clinical implications.","volume":"136","author":"Hardin","year":"2009","journal-title":"Chest"},{"key":"R17-20250902","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9629(15)40528-2","article-title":"Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern.","volume":"317","author":"Shilo","year":"1999","journal-title":"Am J Med Sci"},{"key":"R18-20250902","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.mehy.2013.06.032","article-title":"Delirium: A disturbance of circadian integrity?","volume":"81","author":"Fitzgerald","year":"2013","journal-title":"Med Hypotheses"},{"key":"R19-20250902","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cvdhj.2021.01.004","article-title":"Circadian rhythm in critically ill patients: Insights from the eICU Database.","volume":"2","author":"Beyer","year":"2021","journal-title":"Cardiovasc Digit Health J"},{"key":"R20-20250902","doi-asserted-by":"crossref","first-page":"349","DOI":"10.12788\/jhm.3408","article-title":"Melatonin increasingly used in hospitalized patients.","volume":"15","author":"MacMillan","year":"2020","journal-title":"J Hosp Med"},{"key":"R21-20250902","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/aas.14092","article-title":"The use of melatonin in Danish intensive care departments\u2014a nationwide observational study.","volume":"66","author":"S\u00f8rensen","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R22-20250902","doi-asserted-by":"crossref","first-page":"e31411","DOI":"10.1097\/MD.0000000000031411","article-title":"Prophylactic melatonin for delirium in critically ill patients: A systematic review and meta-analysis with trial sequential analysis.","volume":"101","author":"Yan","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R23-20250902","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/jcm12020435","article-title":"Melatonin or ramelteon for delirium prevention in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials.","volume":"12","author":"Aiello","year":"2023","journal-title":"J Clin Med"},{"key":"R24-20250902","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1097\/CCM.0000000000006574","article-title":"A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.","volume":"53","author":"Lewis","year":"2025","journal-title":"Crit Care Med"},{"key":"R26-20250902","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R27-20250902","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R29-20250902","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R30-20250902","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R31-20250902","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"R32-20250902","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R33-20250902","first-page":"1571","article-title":"Potential role of exogenous melatonin supplement in delirium prevention in critically ill patients: A double-blind randomized pilot study.","volume":"17","author":"Abbasi","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"R34-20250902","first-page":"76","article-title":"Could melatonin prevent vancomycin-induced nephrotoxicity in critically ill patients? A randomized, double-blinded controlled trial.","volume":"14","author":"Abbasi","year":"2023","journal-title":"Caspian J Intern Med"},{"key":"R35-20250902","first-page":"454","article-title":"High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial.","volume":"17","author":"Alizadeh","year":"2022","journal-title":"J Taibah Univ Med Sci"},{"key":"R36-20250902","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10787-022-01096-7","article-title":"Efficacy and safety of oral melatonin in patients with severe COVID-19: A randomized controlled trial.","volume":"31","author":"Ameri","year":"2023","journal-title":"Inflammopharmacology"},{"key":"R37-20250902","doi-asserted-by":"crossref","DOI":"10.62675\/2965-2774.20240144-en","article-title":"Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: A randomized controlled trial.","volume":"36","author":"Bandyopadhyay","year":"2024","journal-title":"Crit Care Sci"},{"key":"R38-20250902","first-page":"3951828","article-title":"Effect of exogenous melatonin administration in critically ill patients on delirium and sleep: A randomized controlled trial.","volume":"2020","author":"Bellapart","year":"2020","journal-title":"Crit Care Res Pract"},{"key":"R39-20250902","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc6871","article-title":"Melatonin therapy to improve nocturnal sleep in critically ill patients: Encouraging results from a small randomised controlled trial.","volume":"12","author":"Bourne","year":"2008","journal-title":"Crit Care"},{"key":"R40-20250902","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.chest.2024.12.030","article-title":"Melatonin low-dose for prevention of delirium in critically ill patients: A multi-centre, randomized, placebo-controlled feasibility trial (MELLOW).","volume":"167","author":"Burry","year":"2025","journal-title":"Chest"},{"key":"R41-20250902","first-page":"122","article-title":"Evaluating the potential effect of melatonin on the post-cardiac surgery sleep disorder.","volume":"10","author":"Dianatkhah","year":"2015","journal-title":"J Tehran Heart Cent"},{"key":"R42-20250902","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/jrpp.JRPP_17_49","article-title":"Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit.","volume":"6","author":"Dianatkhah","year":"2017","journal-title":"J Res Pharm Pract"},{"key":"R45-20250902","doi-asserted-by":"crossref","first-page":"E1286","DOI":"10.1097\/CCM.0000000000004690","article-title":"The effects of melatonin supplementation on sleep quality and assessment of the serum melatonin in ICU patients: A randomized controlled trial.","volume":"48","author":"Gandolfi","year":"2020","journal-title":"Crit Care Med"},{"key":"R46-20250902","first-page":"118","article-title":"Targeting mitochondrial and brain injury markers in acquired brain injuries: A randomized, double-blind, placebo-controlled study with melatonin.","volume":"12","author":"Hakiminia","year":"2022","journal-title":"Adv Pharm Bull"},{"key":"R47-20250902","first-page":"187","article-title":"A double-blind placebo-controlled randomised pilot study of nocturnal melatonin in tracheostomised patients.","volume":"8","author":"Ibrahim","year":"2006","journal-title":"Crit Care Resusc"},{"key":"R48-20250902","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/CCM.0000000000004004","article-title":"Ramelteon for prevention of postoperative delirium: A randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy.","volume":"47","author":"Jaiswal","year":"2019","journal-title":"Crit Care Med"},{"key":"R49-20250902","doi-asserted-by":"crossref","DOI":"10.5812\/aapm-138317","article-title":"The efficacy of dexmedetomidine alone or with melatonin on delirium after coronary artery bypass graft surgery: A randomized clinical trial.","volume":"13","author":"Javaherforooshzadeh","year":"2023","journal-title":"Anesth Pain Med"},{"key":"R50-20250902","first-page":"14","article-title":"The effect of melatonin on cognitive functions following coronary artery bypass grafting: A triple-blind randomized-controlled trial.","volume":"28","author":"Jouybar","year":"2023","journal-title":"J Res Med Sci"},{"key":"R51-20250902","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/11101849.2021.1885956","article-title":"Postoperative delirium after coronary artery bypass graft surgery: Dexmedetomidine infusion alone or with the addition of oral melatonin.","volume":"37","author":"Mahrose","year":"2021","journal-title":"Egypt J Anaesth"},{"key":"R52-20250902","doi-asserted-by":"crossref","first-page":"e12845","DOI":"10.1111\/jpi.12845","article-title":"A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit.","volume":"74","author":"Mansilla-Rosell\u00f3","year":"2023","journal-title":"J Pineal Res"},{"key":"R53-20250902","first-page":"1298","article-title":"Melatonin reduces the need for sedation in ICU patients: A randomized controlled trial.","volume":"81","author":"Mistraletti","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"R54-20250902","first-page":"51","article-title":"Effect of melatonin on stress-induced hyperglycemia and insulin resistance in critically-ill patients: A randomized double-blind, placebo-controlled clinical trial.","volume":"13","author":"Naderi-Behdani","year":"2022","journal-title":"Caspian J Intern Med"},{"key":"R55-20250902","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/CCM.0000000000003132","article-title":"Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: A single-center randomized placebo-controlled trial.","volume":"46","author":"Nishikimi","year":"2018","journal-title":"Crit Care Med"},{"key":"R57-20250902","doi-asserted-by":"crossref","DOI":"10.5812\/jjnpp.64476","article-title":"Evaluating the neuroprotective effect of melatonin on patients with hemorrhagic stroke using serum s100b protein as a prognostic marker.","volume":"16","author":"Sharifnia","year":"2021","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"R58-20250902","doi-asserted-by":"crossref","first-page":"E893","DOI":"10.1532\/hsf.4049","article-title":"Effects of melatonin on postoperative delirium after PCI in elderly patients: A randomized, single-center, double-blind, placebo-controlled trial.","volume":"24","author":"Shi","year":"2021","journal-title":"Heart Surg Forum"},{"key":"R59-20250902","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00068-020-01449-3","article-title":"The effect of melatonin on reduction in the need for sedative agents and duration of mechanical ventilation in traumatic intracranial hemorrhage patients: A randomized controlled trial.","volume":"48","author":"Soltani","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R60-20250902","first-page":"41","article-title":"Investigating the effectiveness of melatonin in the treatment of critically ill patients with COVID-19 hospitalized in the intensive care unit: A double-blind randomized clinical trial.","volume":"38","author":"Tirkan","year":"2024","journal-title":"Med J Islam Repub Iran"},{"key":"R61-20250902","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4103\/0019-5049.193664","article-title":"Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: A double-blind randomised placebo controlled trial.","volume":"60","author":"Vijayakumar","year":"2016","journal-title":"Indian J Anaesth"},{"key":"R62-20250902","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00134-022-06638-9","article-title":"Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): A randomized controlled trial.","volume":"48","author":"Wibrow","year":"2022","journal-title":"Intensive Care Med"},{"key":"R63-20250902","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1532\/hsf.4325","article-title":"Effects of melatonin for delirium in elderly acute heart failure patients: A randomized, single-center, double-blind, and placebo-controlled trial.","volume":"25","author":"Yin","year":"2022","journal-title":"Heart Surg Forum"},{"key":"R64-20250902","first-page":"120","article-title":"Effect of melatonin on delirium after on-pump coronary artery bypass graft surgery: A randomized clinical trial.","volume":"46","author":"Zadeh","year":"2021","journal-title":"Iran J Med Sci"},{"key":"R65-20250902","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1164\/ajrccm.163.2.9912128","article-title":"Abnormal sleep\/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit.","volume":"163","author":"Freedman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R66-20250902","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1378\/chest.06-1795","article-title":"The importance of diagnosing and managing ICU delirium.","volume":"132","author":"Pun","year":"2007","journal-title":"Chest"},{"key":"R67-20250902","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.","volume":"291","author":"Ely","year":"2004","journal-title":"JAMA"},{"key":"R68-20250902","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/PL00012498","article-title":"Melatonin regulation of antioxidant enzyme gene expression.","volume":"59","author":"Mayo","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"R69-20250902","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2005.05.002","article-title":"Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.","volume":"165","author":"Mayo","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R71-20250902","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jamda.2021.10.005","article-title":"Melatonin prescribing in assisted living.","volume":"23","author":"Peketi","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"R72-20250902","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","article-title":"The safety of melatonin in humans.","volume":"36","author":"Andersen","year":"2016","journal-title":"Clin Drug Investig"},{"key":"R74-20250902","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jch.14482","article-title":"Controlled\u2010release oral melatonin supplementation for hypertension and nocturnal hypertension: A systematic review and meta\u2010analysis.","volume":"24","author":"Lee","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R75-20250902","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jfca.2015.09.013","article-title":"Quality control and determination of melatonin in food supplements.","volume":"45","author":"Cerezo","year":"2016","journal-title":"J Food Compos Anal"},{"key":"R76-20250902","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content.","volume":"13","author":"Erland","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"R77-20250902","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1164\/rccm.202301-0184ST","article-title":"Causes, consequences, and treatments of sleep and circadian disruption in the ICU: An official American Thoracic Society Research Statement.","volume":"207","author":"Knauert","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:00:35Z","timestamp":1756821635000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006767","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]}}}